How long does 3C-E last?

The total duration of 3C-E via insufflated is 5 hours to 12 hours. Onset typically occurs within 5 minutes to 1.5 hours. Peak effects last 4 hours to 7 hours.

3C-E — SubstanceWiki

3C-E (3-carbon escaline; chemically 2-(4-ethoxy-3,5-dimethoxyphenyl)-1-aminopropane) is a synthetic psychedelic compound belonging to the substituted amphetamine class and the phenethylamine family. It was first described by Alexander Shulgin in his 1991 compendium PiHKAL: A Chemical Love Story as compound #7, where it is noted for producing particularly challenging, demanding psychedelic experiences. Despite its structural classification as a substituted amphetamine — sharing the 2-aminopropyl chain with MDMA and DOM — 3C-E is a pure psychedelic with negligible entactogenic or stimulant character.

3C-E is the 3-carbon (propyl spacer) homolog of escaline, distinguished from 2C-E (2-carbon spacer) by the additional carbon in the aminoalkyl chain. This modification substantially extends both duration and potency. Users and Shulgin's own reports characterize 3C-E as one of the most intense and demanding compounds in the phenethylamine series — producing rich, complex, and frequently confrontational psychedelic states lasting 8–12 hours, with strong visual and cognitive effects that require significant experience and preparation to navigate productively.

How It Feels

The onset arrives over the course of sixty to ninety minutes as a gradually building stimulant energy that distinguishes itself from other psychedelics by its sheer physical momentum. The heart rate rises noticeably, and a bright, sharp alertness settles into the mind. There is a buzzing quality to the energy -- not anxious, but electric, as though the central nervous system has been tuned to a higher frequency. Appetite vanishes. The body feels lean and eager, primed for activity. The first visual changes appear as a subtle enhancement of color and contrast, but the cognitive stimulation clearly leads the perceptual effects during the come-up.

By the two-hour mark, the psychedelic component has caught up with the stimulant foundation. Visual effects are moderate and precise -- clean, sharp-edged geometric patterns that overlay surfaces with a technical, almost digitally-rendered quality. Colors are vivid and saturated, with a particular emphasis on cool tones: blues, teals, and silvers appear with striking clarity. There is an analytical crispness to the visual field that mirrors the cognitive state. The world looks optimized rather than transformed. Closed-eye visuals present as precise, rapidly shifting structures -- circuit-board geometries and lattice frameworks that feel computational in nature.

The headspace is characterized by intense mental stimulation. Thoughts are rapid, fluid, and remarkably lucid. There is a sense of cognitive expansion -- the ability to hold multiple complex ideas simultaneously and examine them from numerous angles. Creative and analytical thinking both feel enhanced. Conversation is easy and engaging, with ideas flowing freely and articulately. The emotional tone is positive but restrained -- more intellectual excitement than euphoric warmth. The body load is primarily stimulant in character: elevated heart rate, jaw tension, occasional muscle tightness, and a persistent energy that resists relaxation.

The duration is notable. Effects sustain for eight to twelve hours, with the stimulant component often outlasting the psychedelic effects. The descent is slow and can be frustrating, as the visual and introspective content fades while the physical stimulation persists. Sleep is difficult to achieve until the very tail end of the experience. The aftermath typically includes significant fatigue, appetite return, and a need for recovery sleep. The overall experience reads as a hybrid -- half psychedelic, half stimulant -- that rewards those seeking enhanced creative output or extended analytical exploration.

Subjective Effects

The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.

Physical Effects

Physical(15)

Appetite suppression— A distinct decrease in hunger and desire to eat, ranging from reduced interest in food to complete d...
Body load— A diffuse, heavy physical discomfort involving tension, pressure, and malaise in the torso and limbs...
Dehydration— A state of insufficient bodily hydration manifesting as persistent thirst, dry mouth, and physical d...
Dry mouth— A persistent, uncomfortable reduction in saliva production causing the mouth and throat to feel parc...
Increased heart rate— A noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a fo...
Increased libido— A marked enhancement of sexual desire, arousal, and sensitivity to erotic stimuli that can range fro...
Laughter fits— Spontaneous, uncontrollable, and often prolonged episodes of intense laughter that erupt without any...
Nausea— An uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting...
Physical euphoria— An intensely pleasurable bodily sensation that can manifest as waves of warmth, tingling electricity...
Pupil dilation— A visible enlargement of the pupil diameter (mydriasis) that can range from subtle widening to drama...
Sedation— A state of deep physical and mental calming that manifests as a progressive desire to remain still, ...
Seizure— Uncontrolled brain electrical activity causing convulsions and loss of consciousness -- a life-threa...
Stimulation— A state of heightened physical and mental energy characterized by increased wakefulness, elevated mo...
Teeth grinding— An involuntary clenching and rhythmic grinding of the jaw muscles, known clinically as bruxism, that...
Vasoconstriction— A narrowing of blood vessels throughout the body that produces sensations of cold extremities, tingl...

Tactile(1)

Tactile enhancement— The sense of touch becomes dramatically heightened, making physical contact feel intensely pleasurab...

Cognitive & Perceptual Effects

Visual(16)

After images— A visual phenomenon in which a faint, ghostly imprint of a previously viewed image persists in the v...
Brightness alteration— Perceived increase or decrease in environmental brightness beyond actual illumination levels, common...
Colour enhancement— An intensification of the brightness, vividness, and saturation of colors in the external environmen...
Colour shifting— The visual experience of colors on objects and surfaces cycling through continuous, fluid transforma...
Depth perception distortions— Alterations in how the distance of objects within the visual field is perceived, causing layers of s...
Diffraction— The experience of seeing rainbow-like spectrums of color and prismatic halos embedded within bright ...

Detection Methods

Urine Detection

3C-E is not specifically targeted by standard immunoassay-based urine drug panels. However, because 2C-x phenethylamines share structural features with amphetamines, they may trigger false positives on amphetamine immunoassays in some cases. The likelihood of cross-reactivity depends on the specific immunoassay manufacturer and the antibody selectivity used. Urine detection windows for 3C-E are estimated at 24 to 72 hours following ingestion when analyzed by LC-MS/MS methods, though limited pharmacokinetic data exists for many 2C-x compounds.

Blood and Serum Detection

Blood detection windows for 3C-E are approximately 6 to 24 hours after oral administration. Peak plasma concentrations typically occur 1 to 3 hours post-ingestion. The relatively short half-lives of most 2C-x phenethylamines mean that blood testing must be performed promptly to capture detectable concentrations. LC-MS/MS is the only reliable method for quantitative blood analysis.

Standard Drug Panel Inclusion

3C-E is NOT specifically included on standard 5-panel, 10-panel, or 12-panel drug screens. The primary concern for individuals undergoing routine screening is the potential for amphetamine cross-reactivity on immunoassay-based panels. If a presumptive positive for amphetamines occurs, confirmatory testing by GC-MS or LC-MS/MS would not confirm amphetamine and the result would be reported as negative unless the laboratory specifically tests for 2C-x compounds. Most routine laboratories do not include 2C-x phenethylamines in their confirmatory panels.

Confirmatory Methods

Definitive identification of 3C-E requires LC-MS/MS or GC-MS with appropriate reference standards. Some forensic toxicology laboratories include 2C-x phenethylamines in their extended novel psychoactive substance panels. Immunoassay cross-reactivity alone is insufficient for confirmation and would be resolved by standard confirmatory procedures. Quantitative analysis typically requires specific method development as these compounds are not part of routine clinical chemistry workflows.

Reagent Testing (Harm Reduction)

For harm reduction identification, the Marquis reagent is a primary screening tool for 3C-E. The Marquis reagent produces a variable reaction with 3C-E, typically brown to green. As a 3-carbon chain phenethylamine (amphetamine analog), cross-reactivity with amphetamine immunoassays may be more likely than for 2C-x compounds. The Mecke reagent may provide additional color reactions that help differentiate between specific 2C-x variants. The Ehrlich reagent shows no reaction with 2C-x phenethylamines, which can help distinguish them from tryptamines and lysergamides. The Mandelin reagent may produce green to brown reactions depending on the specific compound. Using multiple reagents in combination provides the most reliable field identification, though reagent testing cannot determine purity or dosage.

Interactions

Substance	Status	Note
3-FMA	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
4-MMC	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
8-Chlorotheophylline	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Adrafinil	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Anandamide	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
APICA	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Atropa belladonna	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Benzydamine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Bromantane	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Cannabidiol	Caution	Cannabis can unpredictably intensify psychedelic effects and increase anxiety
Datura	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Dichloropane	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Diphenhydramine	Caution	Unpredictable compounding of hallucinogenic effects with anticholinergic delirium
Ephedrine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Harmala alkaloid	Caution	MAOIs dramatically potentiate psychedelics; drastically reduce dose and exercise extreme caution
Hexedrone	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Methcathinone	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Nicotine	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Oxiracetam	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Peganum harmala	Caution	MAOIs dramatically potentiate psychedelics; drastically reduce dose and exercise extreme caution
Phenylpiracetam	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Rhodiola Rosea	Caution	Increases anxiety, cardiovascular stress, and psychological intensity
Cannabis	Uncertain	—
1,3-Butanediol	Low Risk & Synergy	Cross-tolerance exists; effects compound
25E-NBOH	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-2	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-21	Low Risk & Synergy	Cross-tolerance exists; effects compound
2C-T-7	Low Risk & Synergy	Cross-tolerance exists; effects compound
3-Cl-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-HO-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-HO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCMo	Low Risk & Synergy	Produces unique synergistic effects; often combined
3-MeO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
4-MeO-PCP	Low Risk & Synergy	Produces unique synergistic effects; often combined
Allylescaline	Low Risk & Synergy	Cross-tolerance exists; effects compound
Ayahuasca	Low Risk & Synergy	Cross-tolerance exists; effects compound
Deschloroketamine	Low Risk & Synergy	Produces unique synergistic effects; often combined
DET	Low Risk & Synergy	Cross-tolerance exists; effects compound
Diphenidine	Low Risk & Synergy	Produces unique synergistic effects; often combined
DiPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
DOM	Low Risk & Synergy	Cross-tolerance exists; effects compound
DPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
Efavirenz	Low Risk & Synergy	Cross-tolerance exists; effects compound
Ephenidine	Low Risk & Synergy	Produces unique synergistic effects; often combined
EPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
HXE	Low Risk & Synergy	Produces unique synergistic effects; often combined
Ibogaine	Low Risk & Synergy	Cross-tolerance exists; effects compound
Inhalants	Low Risk & Synergy	Produces unique synergistic effects; often combined
Memantine	Low Risk & Synergy	Produces unique synergistic effects; often combined
MET	Low Risk & Synergy	Cross-tolerance exists; effects compound
Methallylescaline	Low Risk & Synergy	Cross-tolerance exists; effects compound
MiPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
MPT	Low Risk & Synergy	Cross-tolerance exists; effects compound
MXiPr	Low Risk & Synergy	Produces unique synergistic effects; often combined
O-PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
PCE	Low Risk & Synergy	Produces unique synergistic effects; often combined
Psilocybin Mushrooms	Low Risk & Synergy	Cross-tolerance exists; effects compound
Lorazepam	Low Risk & Decrease	Depressants dull psychedelic effects; benzodiazepines are commonly used as trip-killers

Showing 60 key interactions out of 79 total.

Toxicity & Safety

Acute Toxicity

Like related phenethylamine psychedelics, 3C-E has an unknown but presumed low acute toxicity in terms of organ damage. No fatalities attributed specifically to 3C-E pharmacological action have been documented. The primary risks are psychological, cardiovascular, and behavioral (impaired judgment leading to accidents).

Cardiovascular Effects

Alpha-adrenergic and noradrenergic activity produce elevated heart rate, increased blood pressure, and vasoconstriction. These effects are more pronounced than with the classical indole psychedelics (LSD, psilocybin) and represent significant risk for individuals with cardiovascular disease.

Psychological Risks

3C-E is consistently characterized as one of the more demanding phenethylamine psychedelics. Shulgin himself described it as producing particularly intense and challenging states. Acute panic, dissociation, and psychosis-like states are dose-dependent risks, and the extended 8–12 hour duration means a difficult experience is a prolonged ordeal. Personal or family history of psychotic illness or bipolar disorder is an absolute contraindication.

Duration as a Safety Factor

The 8–12 hour duration substantially increases logistical risks — exposure to traffic, social situations, or other hazards during a prolonged period of cognitive impairment. Planning for the full duration is critical.

Addiction Potential

not habit-forming

Overdose Information

Fatal overdose from 3C-E alone, at doses within the typical recreational range, is extremely unlikely based on the available evidence for classical psychedelics. The therapeutic index for most psychedelics is very wide.

However, psychological emergencies can occur and require appropriate response:

Severe anxiety, panic, or psychotic episodes
Dangerous behavior due to impaired reality testing
Self-harm in the context of a distressing experience

Emergency management: If someone is experiencing a severe adverse reaction, move them to a calm, quiet environment. Speak reassuringly. Do not restrain unless there is immediate danger. Benzodiazepines (if available and the person is conscious and able to swallow) can reduce acute anxiety. If psychotic symptoms, self-harm risk, or medical distress is present, seek emergency medical attention.Medical attention: Seek help immediately for seizures, extremely elevated body temperature, signs of serotonin syndrome (agitation, tremor, diarrhea, rapid heart rate), or if the substance consumed is uncertain.

Full	almost immediately after ingestion
Half	3 days
Zero	7 days

3C-E

Quick Dosage

Dosage

insufflated

oral

Duration

insufflated

oral

How It Feels

Subjective Effects

Physical Effects

Physical(15)

Tactile(1)

Cognitive & Perceptual Effects

Visual(16)

Pharmacology

Mechanism of Action

Structural Relationship to 2C-E

Additional Receptors

Pharmacokinetics

Detection Methods

Urine Detection

Blood and Serum Detection

Standard Drug Panel Inclusion

Confirmatory Methods

Reagent Testing (Harm Reduction)

Interactions

History

Shulgin's Synthesis and Documentation

Position in the Phenethylamine Literature

Legal Status

Harm Reduction

Set and Setting

Dose Guidelines

Duration Planning

Reagent Testing

Contraindications

Toxicity & Safety

Acute Toxicity

Cardiovascular Effects

Psychological Risks

Duration as a Safety Factor

Addiction Potential

Overdose Information

Tolerance

Cross-tolerances

Legal Status

Experience Reports (2)

Tips (4)

See Also

Similar by Effects

Same Class

References (4)

Frequently Asked Questions

Cognitive(16)

Multi-sensory(1)

Transpersonal(3)